All News
Apremilast’s Neutral Effects on Cardiovascular Inflammation
d
MedPage Today
An evaluation of a common psoriasis drug's effect on one cardiometabolic risk factor instead showed a favorable impact on a different one.
Read Article
15 RTX patients with no response to 2 doses of SARS-CoV-2 vaccine received a booster. Despite persistent B-cell depletion 7/15 had a response to booster vaccine #Vasculitis22 https://t.co/y8y8Bjnqtp
Richard Conway RichardPAConway ( View Tweet)
The BA.2 variant is now dominant in every region of the United States and accounts for 72% overall for new Covid cases
https://t.co/jjl2AnwOWX @CDCgov https://t.co/ot1GNez51W
Links:
Eric Topol EricTopol ( View Tweet)
Your Psoriatic Questions from RNL 2022
Dr. Jack Cush fields Rheumatologists questions from RNL 2022
QD Clinic is sponsored by RheumNow's PsA All the Way Campaign in April 2022.
https://t.co/DlW5KA3mEo https://t.co/wtTlYJs89l
Links:
Dr. John Cush RheumNow ( View Tweet)
RheumNow's PsA Campaign with enhanced coverage of Psoriatic Disease is sponsored by Janssen. All content is chosen by RheumNow + its faculty. #PsAlways https://t.co/PlUfbo8FNd
Dr. John Cush RheumNow ( View Tweet)
Review of 5 trials shows ixekizumab with higher rates of complete skin & nail clearance compared H2H against to etanercept, guselkumab, ustekinumab, and adalimumab (Data from IXORA-R, IXORA-S, UNCOVER-2, UNCOVER-3, & SPIRIT-H2H trials https://t.co/1JjsDTZX57 #PsA #PsAlways https://t.co/H3AM4Nn2I0
Links:
Dr. John Cush RheumNow ( View Tweet)
Towards More Uniform Methotrexate Dosing in Psoriasis
https://t.co/3GrJADizKK https://t.co/jMAQO5D5Zz
Links:
Dr. John Cush RheumNow ( View Tweet)
ICYMI: Your Rheumatoid Questions from RNL 2022
Rheumatologists questions for Dr. Jack Cush QD
Clinic is sponsored by RheumNow's PsA All the Way Campaign in April 2022
https://t.co/gNk77DIEKK https://t.co/kxJVvRnmkH
Links:
Dr. John Cush RheumNow ( View Tweet)
Study of 221 active RA pts starting a DMARD showed that Sleep disturbance significantly predicted subsequent pain sensitization and conditioned pain modulation. https://t.co/zcUVaMemXN https://t.co/5timIb0aeG
Links:
Dr. John Cush RheumNow ( View Tweet)
ICYMI: Your Lupus Questions from RNL 2022
Rheumatologists questions for Dr. Jack Cush
QD Clinic is sponsored by RheumNow's PsA All the Way Campaign in April 2022
https://t.co/5caTUJIYtr https://t.co/wCraFM8SwW
Links:
Dr. John Cush RheumNow ( View Tweet)
ICYMI: Japanese study using Mendelian randomization (MR) analysis of the association between coffee consumption, gout & uric acid levels - showing coffee consumption can causally reduce gout risk (OR = 0.50), independent of SUA levels https://t.co/aTGkbKDXMg https://t.co/fJqS4nxvDs
Links:
Dr. John Cush RheumNow ( View Tweet)
ICYMI: Study of 1899 ankylosing spondylitis pts(10 RCTs) shows TNFi resp can be predicted - 34% had major resp vs 34% w/ no resp @ wk12. A major resp increased w/ higher CRP, Pt Global & BASDAI-Q2 score & decr w/ higher BMI & BASFI https://t.co/Zo0PFiV3ro https://t.co/FsIiAaykpC
Links:
Dr. John Cush RheumNow ( View Tweet)
ICYMI: Free Teaching PDF on "What is Rheumatoid Arthritis" from JAMA https://t.co/gf2TBv3AjD
Links:
Dr. John Cush RheumNow ( View Tweet)
ICYMI: Study of 119 SLE pts (30 w CKD) shows urinary galectin-3 binding protein as a biomarker, increased w/ active LN, significantly (p<0.001)correlating w/ SLEDAI, SLICC RAS, histologic activity; higher in proliferative vs membranous LN (p=0.04) https://t.co/uUfwJm7JbE https://t.co/mh61wlBN87
Links:
Dr. John Cush RheumNow ( View Tweet)
ICYMI: Infection in lupus is suggested by v. high CRP, PMN-lymph ratio (NLR) Plt-lymph ratio(PLR). Study of 104 hospitalized SLE found all v.high w/ infx & Combined cutoffs of CRP >20 mg/L, NLR >3.5, PLR >151 had 87 sensitivity & 81% specificity for infx https://t.co/OOd5Mftnhl https://t.co/GqSI7HLsbY
Links:
Dr. John Cush RheumNow ( View Tweet)
Join us for Tuesday Night Rheumatology on April 5 at 7pm ET.
Register today!
https://t.co/khydENTDzr https://t.co/mtlfIeyRpc
Links:
Dr. John Cush RheumNow ( View Tweet)
PsA All the Way – All April Long
Join us all April long for our focus on PsA. Tweets, articles, blogs, therapeutic updates and more...all this month!
https://t.co/KEDx73TYHL https://t.co/GaTZ00dQ4N
Links:
Dr. John Cush RheumNow ( View Tweet)
Your Hot Topic Questions from RNL 2022
Rheumatologists questions for Dr. Jack Cush
QD Clinic is sponsored by RheumNow's PsA All the Way Campaign in April 2022
https://t.co/wpPeIwiCxe https://t.co/UY3gDaVeTv
Links:
Dr. John Cush RheumNow ( View Tweet)
Increased Cancer Risk with Autoimmune Disorders (AID)
The incidence and mortality of cancer among AID was studied in a large Chinese cohort, demonstrating that while onset time and risks vary, there is an increased risk of malignancy in AID.
https://t.co/T2WkOWp0cA https://t.co/iNJioAvrIe
Links:
Dr. John Cush RheumNow ( View Tweet)
Heart Risks Elevated in RA Patients Despite Biologic Tx
Hopes that biologic drugs for RA would cancel the extra cardiovascular risks normally seen with the disease dimmed a little in the face of findings from a population-based study from Scandinavia.
https://t.co/qUYG3U2Ind https://t.co/oCpNnDmxIX
Links:
Dr. John Cush RheumNow ( View Tweet)